NVCR icon

NovoCure

218 hedge funds and large institutions have $1.37B invested in NovoCure in 2023 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 84 increasing their positions, 54 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

8% less capital invested

Capital invested by funds: $1.49B → $1.37B (-$118M)

10% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 50

13% less call options, than puts

Call options by funds: $30.9M | Put options by funds: $35.4M

Holders
218
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$30.9M
Puts
$35.4M
Net Calls
Net Calls Change

Top Buyers

1 +$26.4M
2 +$26.1M
3 +$15.1M
4
BlackRock
BlackRock
New York
+$13.9M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$11.6M

Top Sellers

1 -$83.6M
2 -$40.4M
3 -$29.5M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$11.8M
5
Coatue Management
Coatue Management
New York
-$8.03M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$238M
2
$146M
3
$132M
4
$131M
5
$72.3M
6
$57.7M
7
$48.9M
8
$42.4M
9
$33.6M
10
$24.4M
11
$23.8M
12
$22.6M
13
$22M
14
$21.3M
15
$20.4M
16
$15.8M
17
$14.5M
18
$12.7M
19
$11.8M
20
$11.6M
21
$10.1M
22
$10.1M
23
$9.22M
24
$9.21M
25
$8.39M